Molecular interactions in juvenile nasopharyngeal angiofibroma: preliminary signature and relevant review
Authors:
- 1 November 2018
- journal article
- review article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 276 (1) , 93-100
Abstract
The molecular profile of juvenile nasopharyngeal angiofibroma (JNA) is extremely variable. In absence of established molecular signature the molecular targeting seems difficult for this heterogeneous disease. To establish a basic molecular signature, this paper analyses the interaction of 7 markers according to their ranks as per the decreasing scale of molecular expression.Keywords
This publication has 41 references indexed in Scilit:
- c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem CellsCell, 2012
- RETRACTED: Fibroblast growth factor‐2 promotes catabolism via FGFR1‐Ras‐Raf‐MEK1/2‐ERK1/2 axis that coordinates with the PKCδ pathway in human articular chondrocytesJournal of Cellular Biochemistry, 2012
- PI3K/AKT/PTEN Signaling as a Molecular Target in Leukemia AngiogenesisAdvances in Hematology, 2012
- VEGF Stimulates the ERK 1/2 Signaling Pathway and Apoptosis in Cerebral Endothelial Cells After Ischemic ConditionsStroke, 2009
- p53 represses c-Myc through induction of the tumor suppressor miR-145Proceedings of the National Academy of Sciences, 2009
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras ActivationJournal of Biological Chemistry, 2001
- Dual Inactivation of RB and p53 Pathways in RAS-Induced MelanomasMolecular and Cellular Biology, 2001
- The fibroblast growth factor receptor FGFR-4 acts as a ligand dependent modulator of erythroid cell proliferationOncogene, 1999
- Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitroBiochemical and Biophysical Research Communications, 1992